$CYCC
Cyclacel Pharmaceuticals, Inc. Stock $cycc

$cycc Overview Financials Valuation SEC Filings Company Website

2013 Q2 Form 10-Q Financial Statement

#000110465913064020 Filed on August 14, 2013

Income Statement

Concept	2013 Q2	2012 Q4	2012 Q2
Revenue	$264.0K	$10.00K	$26.00K
YoY Change	915.38%		-84.52%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.787M	$2.660M	$2.121M
YoY Change	-15.75%	88.65%	4.28%
% of Gross Profit
Research & Development	$2.631M	$2.000M	$1.717M
YoY Change	53.23%	-9.09%	-7.64%
% of Gross Profit
Depreciation & Amortization	$10.00K	$10.00K	$10.00K
YoY Change	0.0%	-200.0%	-87.5%
% of Gross Profit
Operating Expenses	$4.418M	$4.660M	$3.838M
YoY Change	15.11%	29.09%	-1.41%
Operating Profit	-$4.154M		-$3.812M
YoY Change	8.97%		0.4%
Interest Expense	-$100.0K	-$410.0K	$270.0K
YoY Change	-137.04%		-2800.0%
% of Operating Profit
Other Income/Expense, Net	$5.402M	$0.00	$306.0K
YoY Change	1665.36%	-100.0%	157.14%
Pretax Income	$1.248M	-$5.070M	-$3.506M
YoY Change	-135.6%	39.29%	-4.68%
Income Tax	-$230.0K	-$640.0K	-$127.0K
% Of Pretax Income	-18.43%
Net Earnings	$1.492M	-$4.760M	-$3.577M
YoY Change	-141.71%	30.05%	0.7%
Net Earnings / Revenue	565.15%	-47600.0%	-13757.69%
Basic Earnings Per Share	$0.10		-$0.45
Diluted Earnings Per Share	$0.10	-$119.0M	-$0.45
COMMON SHARES
Basic Shares Outstanding	13.89M shares	8.435M shares	8.428M shares
Diluted Shares Outstanding	13.93M shares		8.428M shares

Balance Sheet

Concept	2013 Q2	2012 Q4	2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$33.67M	$16.41M	$19.96M
YoY Change	68.69%	-32.88%	-3.15%
Cash & Equivalents	$33.67M	$16.41M	$19.96M
Short-Term Investments
Other Short-Term Assets	$45.00K	$10.00K	$113.0K
YoY Change	-60.18%	-95.19%	-83.62%
Inventory			$50.00K
Prepaid Expenses	$459.0K	$358.0K	$486.0K
Receivables			$45.00K
Other Receivables			$850.0K
Total Short-Term Assets	$37.16M	$18.87M	$21.65M
YoY Change	71.59%	-26.94%	-3.55%
LONG-TERM ASSETS
Property, Plant & Equipment	$169.0K	$129.0K	$150.0K
YoY Change	12.67%	-22.75%	-40.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$190.0K	$350.0K
YoY Change
Total Long-Term Assets	$355.0K	$482.0K	$147.0K
YoY Change	141.5%	188.62%	-41.2%
TOTAL ASSETS
Total Short-Term Assets	$37.16M	$18.87M	$21.65M
Total Long-Term Assets	$355.0K	$482.0K	$147.0K
Total Assets	$37.51M	$19.35M	$21.80M
YoY Change	72.06%	-25.56%	-3.96%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.437M	$2.259M	$1.540M
YoY Change	58.25%	31.57%	40.0%
Accrued Expenses	$3.797M	$5.601M	$4.174M
YoY Change	-9.03%	33.9%	24.97%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$6.579M	$9.335M	$6.750M
YoY Change	-2.53%	43.66%	11.75%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.579M	$9.335M	$6.750M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$6.579M	$9.335M	$6.750M
YoY Change	-2.53%	43.66%	11.75%
SHAREHOLDERS EQUITY
Retained Earnings	-$280.2M	-$270.3M
YoY Change		5.13%
Common Stock	$17.00K	$9.000K
YoY Change		12.5%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$30.93M	$10.02M	$15.06M
YoY Change
Total Liabilities & Shareholders Equity	$37.51M	$19.35M	$21.80M
YoY Change	72.05%	-25.56%	-3.96%

Cashflow Statement

Concept	2013 Q2	2012 Q4	2012 Q2
OPERATING ACTIVITIES
Net Income	$1.492M	-$4.760M	-$3.577M
YoY Change	-141.71%	30.05%	0.7%
Depreciation, Depletion And Amortization	$10.00K	$10.00K	$10.00K
YoY Change	0.0%	-200.0%	-87.5%
Cash From Operating Activities	-$5.310M	-$2.460M	-$3.710M
YoY Change	43.13%	-24.54%	-18.82%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00	$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$5.630M	$0.00	$40.00K
YoY Change	13975.0%	-100.0%
Cash From Investing Activities	$5.630M	$0.00	$30.00K
YoY Change	18666.67%	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	19.01M	1.050M	-30.00K
YoY Change	-63466.67%	10400.0%	-83.33%
NET CHANGE
Cash From Operating Activities	-5.310M	-2.460M	-3.710M
Cash From Investing Activities	5.630M	0.000	30.00K
Cash From Financing Activities	19.01M	1.050M	-30.00K
Net Change In Cash	19.33M	-1.410M	-3.710M
YoY Change	-621.02%	-56.48%	-21.89%
FREE CASH FLOW
Cash From Operating Activities	-$5.310M	-$2.460M	-$3.710M
Capital Expenditures	$0.00	$0.00	$0.00
Free Cash Flow	-$5.310M	-$2.460M	-$3.710M
YoY Change	43.13%	-24.54%	-18.82%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	cycc	Share Based Compensation Arrangement By Share Based Payment Award Period For Vesting Of One Fourth Of Award ShareBasedCompensationArrangementByShareBasedPaymentAwardPeriodForVestingOfOneFourthOfAward	P1Y
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.04
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.00
	us-gaap	Proceeds From Grantors ProceedsFromGrantors	1900000	USD
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">Use of Estimates</font></i></b></p> <p style="MARGIN: 0in 0in 0pt;"> </p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities and related disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Critical estimates include inputs used to determine stock-based compensation expense and the fair value of financial instruments and other liabilities measured at fair value. Cyclacel reviews its estimates on an ongoing basis. The estimates are based on historical experience and on various other assumptions that the Company believes to be reasonable under the circumstances. Actual results may differ from these estimates. Cyclacel believes the judgments and estimates required by the following accounting policies to be significant in the preparation of the Company’s consolidated financial statements.</font></p> </div>
CY2012Q4	us-gaap	Deferred Income Taxes And Other Tax Receivable Current DeferredIncomeTaxesAndOtherTaxReceivableCurrent	1033000	USD
CY2012Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	358000	USD
CY2013Q2	us-gaap	Grants Receivable Current GrantsReceivableCurrent	277000	USD
CY2012Q4	cycc	Sales Tax Receivable Current SalesTaxReceivableCurrent	45000	USD
CY2012Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	153000	USD
CY2012Q4	us-gaap	Other Assets Current OtherAssetsCurrent	10000	USD
CY2013Q2	us-gaap	Deferred Income Taxes And Other Tax Receivable Current DeferredIncomeTaxesAndOtherTaxReceivableCurrent	1517000	USD
CY2013Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	459000	USD
CY2012Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	1599000	USD
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">Concentration of Credit Risk</font></i></b></p> <p style="MARGIN: 0in 0in 0pt;"> </p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Financial instruments that potentially subject the Company to concentration of credit risk are primarily cash and cash equivalents. The Company maintains its cash and cash equivalent balances in the form of business checking accounts, money market accounts and commercial paper, the balances of which at times may exceed federal insurance limits. Cash equivalents are invested in accordance with the Company’s investment policy. The investment policy includes guidelines on the quality of the institutions and financial instruments and defines allowable investments that the Company believes minimizes the exposure to concentration of credit risk.</font></p> </div>
CY2013Q2	cycc	Sales Tax Receivable Current SalesTaxReceivableCurrent	219000	USD
CY2013Q2	us-gaap	Deposits Assets Current DepositsAssetsCurrent	153000	USD
CY2012Q4	cycc	Accrued Research And Development Costs Current AccruedResearchAndDevelopmentCostsCurrent	3623000	USD
CY2012Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1118000	USD
CY2012Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	860000	USD
CY2012Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5601000	USD
CY2013Q2	cycc	Accrued Research And Development Costs Current AccruedResearchAndDevelopmentCostsCurrent	3136000	USD
CY2013Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	137000	USD
CY2013Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	524000	USD
CY2013Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3797000	USD
CY2013Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33668000	USD
CY2013Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	32200000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16412000	USD
CY2012Q4	us-gaap	Cash Cash	4100000	USD
CY2012Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	12300000	USD
	us-gaap	Customer Refundable Fees Revenue Recognized CustomerRefundableFeesRevenueRecognized	0	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2013Q2	us-gaap	Number Of Countries In Which Entity Operates NumberOfCountriesInWhichEntityOperates	2	area
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3040457	shares
CY2012Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3040457	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2228230	shares
CY2013Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2075507	shares
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	0	USD
CY2013Q2	us-gaap	Other Assets Current OtherAssetsCurrent	45000	USD
CY2013Q2	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	2670000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P4Y
CY2010	cycc	Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Awards Vesting Each Month ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfAwardsVestingEachMonth	0.0208	pure
	cycc	Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Awards Vesting Each Month After One Year ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfAwardsVestingEachMonthAfterOneYear	0.0208	pure
	cycc	Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Award Vesting At Year One ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfAwardVestingAtYearOne	0.25	pure
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	211000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	146000	USD
CY2012Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	109000	USD
CY2013Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	74000	USD
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	1428571	shares
CY2012Q2	cycc	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized Prior To Amendment ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedPriorToAmendment	742857	shares
CY2013Q2	cycc	Share Based Compensation Arrangement By Share Based Payment Award Forfeiture Rate Change ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeitureRateChange	0.00	pure
CY2013Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	420682	shares
CY2013Q2	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	0	shares
CY2013Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1591795	shares
CY2013Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights	17.06
	dei	Document Type DocumentType	10-Q
	dei	Document Period End Date DocumentPeriodEndDate	2013-06-30
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2013Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	17715113	shares
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
CY2012Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1599000	USD
CY2012Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	861000	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	18872000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	129000	USD
CY2012Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Noncurrent AssetsOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	353000	USD
CY2012Q4	us-gaap	Assets Assets	19354000	USD
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2259000	USD
CY2012Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1120000	USD
CY2012Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	20000	USD
CY2012Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	335000	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	9335000	USD
CY2012Q4	us-gaap	Liabilities Liabilities	9335000	USD
CY2012Q4	us-gaap	Preferred Stock Value PreferredStockValue	1000	USD
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	9000	USD
CY2012Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	280211000	USD
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	48000	USD
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-270250000	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	10019000	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	19354000	USD
CY2013Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q2	us-gaap	Assets Current AssetsCurrent	37155000	USD
CY2013Q2	us-gaap	Assets Assets	37510000	USD
CY2013Q2	us-gaap	Liabilities Current LiabilitiesCurrent	6579000	USD
CY2013Q2	us-gaap	Liabilities Liabilities	6579000	USD
CY2013Q2	us-gaap	Stockholders Equity StockholdersEquity	30931000	USD
CY2013Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	37510000	USD
CY2013Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2013Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2012Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2013Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	420682	shares
CY2012Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	1213142	shares
CY2012Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	1213142	shares
CY2013Q2	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	5006116000	USD
CY2012Q4	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	14436390000	USD
CY2013Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2013Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	17715113	shares
CY2013Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	17715113	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8686484	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8686484	shares
	us-gaap	License And Services Revenue LicenseAndServicesRevenue	3100000	USD
	us-gaap	Revenue From Grants RevenueFromGrants	26000	USD
	us-gaap	Revenue From Grants RevenueFromGrants	4193000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	7293000	USD
CY2012Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1717000	USD
CY2012Q2	us-gaap	Revenue From Grants RevenueFromGrants	26000	USD
CY2012Q2	us-gaap	Sales Revenue Net SalesRevenueNet	26000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	26000	USD
CY2013Q2	us-gaap	Sales Revenue Net SalesRevenueNet	264000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3064000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	476000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	196602000	USD
CY2012Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2121000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3889000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	93881000	USD
	cycc	Goodwill And Intangible Asset Impairment Net Discontinued Operations GoodwillAndIntangibleAssetImpairmentNetDiscontinuedOperations	2747000	USD
	us-gaap	Other Restructuring Costs OtherRestructuringCosts	2634000	USD
CY2012Q2	us-gaap	Costs And Expenses CostsAndExpenses	3838000	USD
CY2013Q2	us-gaap	Costs And Expenses CostsAndExpenses	4418000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	6953000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	8681000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	295864000	USD
CY2012Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-3812000	USD
CY2013Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-4154000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6927000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-8205000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-288571000	USD
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	-3550000	USD
	cycc	Payment Under Guarantee PaymentUnderGuarantee	1652000	USD
	cycc	Expense Related To Stock Purchase Agreement ExpenseRelatedToStockPurchaseAgreement	423000	USD
CY2012Q2	cycc	Change In Valuation Of Economic Rights ChangeInValuationOfEconomicRights	-146000	USD
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	50000	USD
	cycc	Change In Valuation Of Economic Rights ChangeInValuationOfEconomicRights	-547000	USD
CY2012Q2	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	8000	USD
	cycc	Change In Valuation Of Economic Rights ChangeInValuationOfEconomicRights	-90000	USD
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	6378000	USD
CY2012Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	117000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	231000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-3986000	USD
CY2012Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	6000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	12000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	13751000	USD
	us-gaap	Interest Expense InterestExpense	4567000	USD
CY2012Q2	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	29000	USD
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	76000	USD
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	5581000	USD
CY2012Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	306000	USD
CY2013Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	5402000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	459000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	6097000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	12079000	USD
CY2012Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-3506000	USD
CY2013Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1248000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-6468000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-2108000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-276492000	USD
CY2012Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-127000	USD
CY2013Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-230000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-295000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-20283000	USD
CY2012Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-3379000	USD
CY2013Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	1478000	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-6173000	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-1620000	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-256209000	USD
CY2012Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-198000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-359000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-12116000	USD
CY2012Q2	us-gaap	Net Income Loss NetIncomeLoss	-3577000	USD
	cycc	Change In Valuation Of Liabilities Measured At Fair Value ChangeInValuationOfLiabilitiesMeasuredAtFairValue	1120000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	146000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	19549000	USD
	us-gaap	Payments For Restructuring PaymentsForRestructuring	-1779000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2517000	USD
	cycc	Transaction Costs On Sale Of Economic Rights TransactionCostsOnSaleOfEconomicRights	33000	USD
	cycc	Transaction Costs On Sale Of Economic Rights TransactionCostsOnSaleOfEconomicRights	33000	USD
	cycc	Disposal Group Including Discontinued Operation Gain Loss On Termination Of Distribution Agreement DisposalGroupIncludingDiscontinuedOperationGainLossOnTerminationOfDistributionAgreement	1192000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	307000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1124000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1421000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-268325000	USD
	cycc	Change In Valuation Of Liabilities Measured At Fair Value ChangeInValuationOfLiabilitiesMeasuredAtFairValue	7475000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	30000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	36000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	12651000	USD
	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	-709000	USD
	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	-1530000	USD
	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	-5075000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-7476000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-10682000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-235844000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	3763000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10000	USD
	cycc	Dividends On Preferred Ordinary Shares DividendsOnPreferredOrdinaryShares	38123000	USD
	cycc	Redeemable Preferred Stocks Dividends RedeemablePreferredStocksDividends	8366000	USD
	cycc	Redeemable Preferred Stocks Dividends RedeemablePreferredStocksDividends	11881000	USD
CY2012Q2	cycc	Dividends Preferred Stocks DividendsPreferredStocks	182000	USD
	cycc	Dividends Preferred Stocks DividendsPreferredStocks	364000	USD
	cycc	Dividends Preferred Stocks DividendsPreferredStocks	4570000	USD
CY2012Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3759000	USD
CY2013Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1429000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6896000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10141000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-322899000	USD
CY2012Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-3564000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-6511000	USD
CY2013Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1680000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-268330000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1643000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-1590000	USD
	us-gaap	Accretion Expense AccretionExpense	100000	USD
	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	-2297000	USD
	cycc	Change In Valuation Of Liabilities Measured At Fair Value ChangeInValuationOfLiabilitiesMeasuredAtFairValue	140000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	886000	USD
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	221000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-7747000	USD
	us-gaap	Recognition Of Deferred Revenue RecognitionOfDeferredRevenue	98000	USD
	cycc	Stock Option Plan Expenses StockOptionPlanExpenses	1215000	USD
	cycc	Issuance Of Stocks And Warrants For Services Or Claims IssuanceOfStocksAndWarrantsForServicesOrClaims	446000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	62000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-38000	USD
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	7934000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	211000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	92000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8941000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-264000	USD
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.86
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-264000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	62000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	225000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	156657000	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	162729000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	52000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	5672000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-643000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	3719000	USD
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	121678000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2886000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	22495000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	118047000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	34000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	267000	USD
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	192000	USD
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	2090000	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	455000	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	414000	USD
	us-gaap	Proceeds From Loans ProceedsFromLoans	9103000	USD
	cycc	Proceeds Of Committable Loan Notes Issued From Shareholders ProceedsOfCommittableLoanNotesIssuedFromShareholders	8883000	USD
	us-gaap	Loans And Leases Receivable Related Parties Collections LoansAndLeasesReceivableRelatedPartiesCollections	-1645000	USD
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	17915000	USD
	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	1951000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	2920000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	22303000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	269737000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	19000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	-37000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	418000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-4485000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	17256000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	33668000	USD
	us-gaap	Proceeds From Interest Received ProceedsFromInterestReceived	8000	USD
	us-gaap	Proceeds From Interest Received ProceedsFromInterestReceived	5000	USD
	us-gaap	Proceeds From Interest Received ProceedsFromInterestReceived	11761000	USD
	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	18772000	USD
	us-gaap	Interest Paid Net InterestPaidNet	-1914000	USD
	cycc	Acquisitions Of Equipment Purchased Through Capital Leases AcquisitionsOfEquipmentPurchasedThroughCapitalLeases	3470000	USD
	cycc	Issuance Of Ordinary Shares In Connection With License Agreements IssuanceOfOrdinarySharesInConnectionWithLicenseAgreements	592000	USD
	cycc	Issuance Of Ordinary Shares On Conversion Of Bridging Loan IssuanceOfOrdinarySharesOnConversionOfBridgingLoan	1638000	USD
	cycc	Issuance Of Preferred Ordinary Class C Shares On Conversion Of Secured Convertible Loan Notes And Accrued Interest IssuanceOfPreferredOrdinaryClassCSharesOnConversionOfSecuredConvertibleLoanNotesAndAccruedInterest	8893000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Other Liabilities Assumed1 NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1	1122000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24449000	USD
CY2012Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19964000	USD
	cycc	Stock Issued During Period Shares Warrants Exercised StockIssuedDuringPeriodSharesWarrantsExercised	0	shares
	cycc	Stock Issued During Period Shares Warrants Exercised StockIssuedDuringPeriodSharesWarrantsExercised	0	shares
CY2012Q2	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	0	shares
CY2013Q2	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	0	shares
CY2013Q2	cycc	Stock Issued During Period Shares Warrants Exercised StockIssuedDuringPeriodSharesWarrantsExercised	0	shares
CY2012Q2	cycc	Stock Issued During Period Shares Warrants Exercised StockIssuedDuringPeriodSharesWarrantsExercised	0	shares
CY2013Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2670000	USD
CY2013Q2	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	817000	USD
CY2013Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	169000	USD
CY2013Q2	us-gaap	Assets Of Disposal Group Including Discontinued Operation Noncurrent AssetsOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	186000	USD
CY2013Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2437000	USD
CY2013Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	20000	USD
CY2013Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	325000	USD
CY2013Q2	us-gaap	Common Stock Value CommonStockValue	17000	USD
CY2013Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	311125000	USD
CY2013Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-5000	USD
CY2013Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-280206000	USD
CY2013Q2	us-gaap	Revenue From Grants RevenueFromGrants	264000	USD
	us-gaap	Revenue From Grants RevenueFromGrants	476000	USD
CY2013Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2631000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4211000	USD
CY2013Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1787000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4470000	USD
	cycc	Change In Valuation Of Economic Rights ChangeInValuationOfEconomicRights	-570000	USD
CY2013Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-101000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	19000	USD
CY2013Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	3000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	4000	USD
CY2013Q2	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	5500000	USD
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	5504000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-488000	USD
CY2013Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	14000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	30000	USD
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	1492000	USD
CY2013Q2	cycc	Dividends Preferred Stocks DividendsPreferredStocks	63000	USD
	cycc	Dividends Preferred Stocks DividendsPreferredStocks	185000	USD
CY2012Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8428154	shares
CY2013Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13885442	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8125621	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11849270	shares
CY2012Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	2398000	USD
CY2013Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-14000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-931000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	6638000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	7353000	USD
CY2012Q2	cycc	Other Comprehensive Income Unrealized Foreign Exchange On Intercompany Loans Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeUnrealizedForeignExchangeOnIntercompanyLoansNetOfTaxPortionAttributableToParent	-2385000	USD
CY2013Q2	cycc	Other Comprehensive Income Unrealized Foreign Exchange On Intercompany Loans Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeUnrealizedForeignExchangeOnIntercompanyLoansNetOfTaxPortionAttributableToParent	202000	USD
	cycc	Other Comprehensive Income Unrealized Foreign Exchange On Intercompany Loans Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeUnrealizedForeignExchangeOnIntercompanyLoansNetOfTaxPortionAttributableToParent	952000	USD
	cycc	Other Comprehensive Income Unrealized Foreign Exchange On Intercompany Loans Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeUnrealizedForeignExchangeOnIntercompanyLoansNetOfTaxPortionAttributableToParent	-6691000	USD
	cycc	Other Comprehensive Income Unrealized Foreign Exchange On Intercompany Loans Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeUnrealizedForeignExchangeOnIntercompanyLoansNetOfTaxPortionAttributableToParent	-7358000	USD
CY2012Q2	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	-198000	USD
CY2013Q2	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	24000	USD
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	-359000	USD
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	50000	USD
CY2013Q2	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	10000	USD
	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	20000	USD
	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	357000	USD
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	-11759000	USD
CY2012Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.42
CY2012Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.02
CY2012Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.45
CY2013Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.10
CY2013Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.00
CY2013Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.10
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.80
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.04
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.85
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.86
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.86
CY2012Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.42
CY2013Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.10
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.80
CY2012Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.02
CY2013Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.00
CY2012Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.45
CY2013Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.10
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.85
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.86
CY2012Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8428154	shares
CY2013Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13927371	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8125621	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11849270	shares
	us-gaap	Gain Loss On Disposition Of Intangible Assets GainLossOnDispositionOfIntangibleAssets	5500000	USD
	us-gaap	Gain Loss On Disposition Of Intangible Assets GainLossOnDispositionOfIntangibleAssets	5500000	USD
	us-gaap	Proceeds From Sale Of Intangible Assets ProceedsFromSaleOfIntangibleAssets	5500000	USD
	us-gaap	Proceeds From Sale Of Intangible Assets ProceedsFromSaleOfIntangibleAssets	5500000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	-166000	USD
CY2013Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	41929	shares
	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	0	shares
CY2012Q2	cycc	Income Loss From Continuing Operations Basic And Diluted IncomeLossFromContinuingOperationsBasicAndDiluted	-3561000	USD
CY2013Q2	cycc	Income Loss From Continuing Operations Basic And Diluted IncomeLossFromContinuingOperationsBasicAndDiluted	1415000	USD
	cycc	Income Loss From Continuing Operations Basic And Diluted IncomeLossFromContinuingOperationsBasicAndDiluted	-6537000	USD
	cycc	Income Loss From Continuing Operations Basic And Diluted IncomeLossFromContinuingOperationsBasicAndDiluted	-10171000	USD
	cycc	Issuance Of Ordinary Shares In Lieu Of Cash Bonus IssuanceOfOrdinarySharesInLieuOfCashBonus	181000	USD

Files In Submission

Name	View Source	Status
0001104659-13-064020-index-headers.html	Edgar Link	pending
0001104659-13-064020-index.html	Edgar Link	pending
0001104659-13-064020.txt	Edgar Link	pending
0001104659-13-064020-xbrl.zip	Edgar Link	pending
a13-13907_110q.htm	Edgar Link	pending
a13-13907_1ex31d1.htm	Edgar Link	pending
a13-13907_1ex31d2.htm	Edgar Link	pending
a13-13907_1ex32d1.htm	Edgar Link	pending
a13-13907_1ex32d2.htm	Edgar Link	pending
cycc-20130630.xml	Edgar Link	completed
cycc-20130630.xsd	Edgar Link	pending
cycc-20130630_cal.xml	Edgar Link	unprocessable
cycc-20130630_def.xml	Edgar Link	unprocessable
cycc-20130630_lab.xml	Edgar Link	unprocessable
cycc-20130630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
R1.htm	Edgar Link	pending
R1.xml	Edgar Link	unprocessable
R10.htm	Edgar Link	pending
R10.xml	Edgar Link	unprocessable
R11.htm	Edgar Link	pending
R11.xml	Edgar Link	unprocessable
R12.htm	Edgar Link	pending
R12.xml	Edgar Link	unprocessable
R13.htm	Edgar Link	pending
R13.xml	Edgar Link	unprocessable
R14.htm	Edgar Link	pending
R14.xml	Edgar Link	unprocessable
R15.htm	Edgar Link	pending
R15.xml	Edgar Link	unprocessable
R16.htm	Edgar Link	pending
R16.xml	Edgar Link	unprocessable
R17.htm	Edgar Link	pending
R17.xml	Edgar Link	unprocessable
R18.htm	Edgar Link	pending
R18.xml	Edgar Link	unprocessable
R19.htm	Edgar Link	pending
R19.xml	Edgar Link	unprocessable
R2.htm	Edgar Link	pending
R2.xml	Edgar Link	unprocessable
R20.htm	Edgar Link	pending
R20.xml	Edgar Link	unprocessable
R21.htm	Edgar Link	pending
R21.xml	Edgar Link	unprocessable
R22.htm	Edgar Link	pending
R22.xml	Edgar Link	unprocessable
R23.htm	Edgar Link	pending
R23.xml	Edgar Link	unprocessable
R24.htm	Edgar Link	pending
R24.xml	Edgar Link	unprocessable
R25.htm	Edgar Link	pending
R25.xml	Edgar Link	unprocessable
R26.htm	Edgar Link	pending
R26.xml	Edgar Link	unprocessable
R27.htm	Edgar Link	pending
R27.xml	Edgar Link	unprocessable
R28.htm	Edgar Link	pending
R28.xml	Edgar Link	unprocessable
R29.htm	Edgar Link	pending
R29.xml	Edgar Link	unprocessable
R3.htm	Edgar Link	pending
R3.xml	Edgar Link	unprocessable
R30.htm	Edgar Link	pending
R30.xml	Edgar Link	unprocessable
R31.htm	Edgar Link	pending
R31.xml	Edgar Link	unprocessable
R32.htm	Edgar Link	pending
R32.xml	Edgar Link	unprocessable
R33.htm	Edgar Link	pending
R33.xml	Edgar Link	unprocessable
R34.htm	Edgar Link	pending
R34.xml	Edgar Link	unprocessable
R35.htm	Edgar Link	pending
R35.xml	Edgar Link	unprocessable
R36.htm	Edgar Link	pending
R36.xml	Edgar Link	unprocessable
R37.htm	Edgar Link	pending
R37.xml	Edgar Link	unprocessable
R38.htm	Edgar Link	pending
R38.xml	Edgar Link	unprocessable
R39.htm	Edgar Link	pending
R39.xml	Edgar Link	unprocessable
R4.htm	Edgar Link	pending
R4.xml	Edgar Link	unprocessable
R40.htm	Edgar Link	pending
R40.xml	Edgar Link	unprocessable
R41.htm	Edgar Link	pending
R41.xml	Edgar Link	unprocessable
R42.htm	Edgar Link	pending
R42.xml	Edgar Link	unprocessable
R43.htm	Edgar Link	pending
R43.xml	Edgar Link	unprocessable
R44.htm	Edgar Link	pending
R44.xml	Edgar Link	unprocessable
R45.htm	Edgar Link	pending
R45.xml	Edgar Link	unprocessable
R5.htm	Edgar Link	pending
R5.xml	Edgar Link	unprocessable
R6.htm	Edgar Link	pending
R6.xml	Edgar Link	unprocessable
R7.htm	Edgar Link	pending
R7.xml	Edgar Link	unprocessable
R8.htm	Edgar Link	pending
R8.xml	Edgar Link	unprocessable
R9.htm	Edgar Link	pending
R9.xml	Edgar Link	unprocessable
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CYCC
Cyclacel Pharmaceuticals, Inc. Stock $cycc

2013 Q2 Form 10-Q Financial Statement

#000110465913064020 Filed on August 14, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CYCC Cyclacel Pharmaceuticals, Inc. Stock $cycc

2013 Q2 Form 10-Q Financial Statement

#000110465913064020 Filed on August 14, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CYCC
Cyclacel Pharmaceuticals, Inc. Stock $cycc